The International Air Transport Association (IATA) and the global collaborative platform Pharma.Aero have joined forces to strengthen IATA’s CEIV Pharma programme

Over a two-year period, the two organisations conducted a study of the CEIV Pharma (Certification for the Excellence in Pharmaceutical Handling ) programme, involving certified entities, pharmaceutical manufacturers, and professionals within the air logistics sector. The findings of this comprehensive study were published in a White Paper.

This project identified a number of opportunities within the programme, including:

– Building awareness: increasing engagement with authorities to ensure ongoing integration of global best practices into the programme

Continuous improvements of the certification process: training modules, checklist layout and Independent Validator qualifications to ensure a strong foundation for the future growth of the certification

Increase visibility of IATA CEIV Pharma within the life science manufacturing sector

Expand network to make it more accessible to smaller enterprises and in underserved markets

Enhance IATA ONE Source, an industry platform for validated aviation capability and infrastructure information to enable integration with other platforms.

 

The project identified several opportunities within the CEIV Pharma programme
The project identified several opportunities within the CEIV Pharma programme IATA/ Getty Images